Tunneling nanotube-mediated intercellular spread of SARS-CoV-2 variants in epithelial cells reveals a host-targeted

Gurleen Kaur1, Ritika Khatri2, Varun Kumar3

  • 1Centre for Virus Research, Therapeutics and Vaccines, BRIC-Translational Health Science & Technology Institute, NCR Biotech Science Cluster, Faridabad, Haryana 121001, India; Manipal Academy of Higher Education, Manipal, Karnataka 576104, India.